Harvard Bioscience, Inc.(HBIO) stock price and fundamentals

Medical - Instruments & Supplies · Holliston, MA

$8.64+0.14 (+1.65%)

Delayed quote: Oct 6, 2026, 11:19 AM EDT

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Holliston, MA

328 employees

www.harvardbioscience.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: John D. Duke

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1HBIO	$39.33M	$8.72	+2.59%	+88.73%	-34.33%	-11.05%	N/A
2NEPH	$39.63M	$3.65	+2.82%	-25.47%	-15.93%	+1.80%	vs HBIO
3MGX	$40.28M	$1.07	+2.88%	-60.58%	N/A	N/A	vs HBIO
4IXHL	$38.03M	$3.18	-0.98%	-77.63%	N/A	N/A	vs HBIO
5EDSA	$36.99M	$3.84	-1.80%	+52.43%	-39.88%	-40.32%	vs HBIO
6FLNA	$41.72M	$0.86	-0.70%	N/A	N/A	N/A	vs HBIO

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$-0.17	$-0.17	$-0.17	1
Quarter ending Dec 2026	$0.16	$0.23	$0.30	2
Quarter ending Mar 2027	$-0.01	$-0.01	$-0.01	1
Quarter ending Jun 2027	$0.13	$0.13	$0.13	1

Period	Low	Avg	High	# Analysts
FY 2026	$-0.38	$-0.38	$-0.38	1
FY 2027	$0.37	$0.65	$0.92	2

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$21.60M	$21.80M	$22.00M	2
Quarter ending Dec 2026	$24.50M	$24.50M	$24.50M	2
Quarter ending Mar 2027	$21.80M	$21.80M	$21.80M	1
Quarter ending Jun 2027	$23.70M	$23.70M	$23.70M	1

FY 2026	$89.35M	$89.80M	$90.25M	1
FY 2027	$93.60M	$94.55M	$95.50M	2

Harvard Bioscience, Inc.(HBIO) stock price and fundamentals

Valuation

Yields

HBIO Price Chart

Business at a glance

HBIO Key Metrics

Total Return CAGR

HBIO Fundamental Charts

Revenue CAGR

Operating Cash Flow CAGR

Free Cash Flow CAGR

EBITDA CAGR

HBIO Selected Revenue Disclosures

Product / business disclosures (FY 2025)

Geographic disclosures (FY 2025)

HBIO Earnings Preview

Similar-Size Sector Stocks

HBIO Competitors' Key Metrics

HBIO Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

HBIO Analyst Ratings

HBIO Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates